• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Lorlatinib’s Unique Challenges: Managing Cognitive and Metabolic AEs

Opinion
Video

Panelists discuss how lorlatinib’s unique adverse event (AE) profile, including cognitive effects, hypercholesterolemia, and peripheral neuropathy, impacts treatment selection and patient management.

Related Videos
4 experts in this video
4 experts in this video
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.